Omicron variant unlikely to impact FMCG, pharma, telecom stocks, say analysts
The emergence of a stronger variant of COVID-19 - Omicron - may not have a strong impact on the performances of companies operating in fast-moving consumer goods (FMCG), pharmaceutical, and telecom sectors, say analysts. On Friday, equity markets in India and several countries declined sharply followed by the reports of the new variant in South Africa.
